Hypertelmi Plus Tablet 40/12.5mg

Adult dose

In patients whose blood pressure is not adequately controlled with telmisartan alone, take this medication once daily with or without food, along with a beverage. It is recommended to adjust the dosages of individual components before switching to this fixed-dose combination. When clinically appropriate, direct conversion from monotherapy to this combination may also be considered. - The combination of telmisartan/hydrochlorothiazide 40/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The combination of telmisartan/hydrochlorothiazide 80/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The combination of telmisartan/hydrochlorothiazide 80/25mg may be administered to patients whose blood pressure is not adequately controlled with either telmisartan 80mg or hydrochlorothiazide 12.5mg alone or in combination. Before starting this medication, sodium or volume depletion must be corrected. Patients with renal impairment No dose adjustment is necessary for patients with mild to moderate renal impairment. This medication should not be administered to patients with severe renal impairment (creatinine clearance <30mL/min). Periodic monitoring of renal function is recommended. Patients with liver impairment This medication should be administered with caution to patients with mild to moderate liver impairment. Do not exceed 40/12.5mg daily. This medication should not be administered to patients with severe liver impairment (refer to usage precautions 2). Thiazide diuretics should be used cautiously in patients with liver dysfunction. Elderly patients Dose adjustment is not necessary. Pediatric patients Safety and efficacy for children under 18 years of age have not been established for this medication.

Child dose

Safety and efficacy for children under 18 years of age have not been established for this medication.

This medication should not be used during pregnancy, especially in the second and third trimesters, as it can cause serious abnormalities in the fetus. If pregnancy is confirmed, the use of this medication should be discontinued immediately and alternative treatment should be considered. Patients with allergies to any of the ingredients in this medication, certain liver or kidney diseases, pregnant women, and nursing mothers should not take this medication. Additionally, patients with severe kidney problems such as obstructive biliary disease, acute nephritis, or anuria should avoid taking it. Elderly patients or those with high potassium levels or liver impairment should use this medication with caution, and special attention is needed in those with heart valve disease or ischemic heart disease. There is an increased risk of skin cancer while taking this medication, so sun exposure should be limited, and skin condition should be monitored regularly. This medication lowers blood pressure and may cause side effects such as dizziness, hypotension, orthostatic hypotension, and cardiac arrhythmias, as well as dyspepsia, vomiting, diarrhea, and skin rashes. Electrolyte imbalances may occur, so potassium, sodium, and other levels should be periodically checked through blood tests. Furthermore, this medication can interact with other drugs, so especially when used with lithium, potassium-sparing diuretics, non-steroidal anti-inflammatory drugs, or other antihypertensives, it is essential to consult with a doctor or pharmacist. Caution is advised when driving or operating machinery, as dizziness or drowsiness may occur. This medication is not recommended for children as its safety and efficacy have not been established, and it should be stored out of reach of children. It is advisable to take it immediately after removing it from the sealed package.

Serious side effects

Urticaria, severe edema (angioedema), tightness in the chest, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, skin peeling, mucosal pain in the mouth/eyes, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities accompanied by cough and fever, yellowing of the skin or eyes (jaundice), extreme drowsiness, sudden and severe headaches, thunderclap headaches, seizures, confusion of consciousness, visual disturbances, paralysis,

Mild side effects

• Dizziness
• diarrhea
• cough
• pharyngitis
• sinusitis
• hypokalemia
• hyperuricemia
• anxiety
• depression
• insomnia

This medication should be stored in a well-sealed container to prevent exposure to air or moisture. It is recommended to keep it at room temperature between 1°C and 30°C. Proper storage will help maintain the medication's effectiveness over time.

Appearance

White or almost white, biconvex round tablets

Package unit

30 tablets (10 tablets/blister x 3)